HCPlive (2/2, Derman) reported that a “new study found antidepressants in the selective serotonin reuptake inhibitor (SSRI) or serotonin and norepinephrine reuptake inhibitor (SNRI) class did not increase the risk of hemorrhagic stroke or other serious bleeding events in most ischemic stroke survivors.” Lead investigator Kent P. Simmonds, DO, PhD., from the University of Texas Southwestern Medical Center in Dallas, said, “Our results should reassure clinicians that for most stroke survivors, it is safe to prescribe SSRI and/or SNRI antidepressants early after stroke to treat post-stroke depression and anxiety, which may help optimize their patients’ recovery.” The study was published in Stroke and presented at the International Stroke Conference.
Related Links:
— “Antidepressants from SSRI or SNRI Classes Were Safe for Most Stroke Survivors,”Chelsie Derman, HCPlive, February 2, 2024